Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03349385 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of Secondary Revascularization

Study acronym: REVASEC
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Jan 15, 2025 to Dec 15, 2025
    • Site details revised
    v9
  2. Enrollment target: estimated 1000 to confirmed 869
    • Study sites: 2 to 1
    • Publications: 4 to 2
    v8
  3. Primary completion date changed from estimate of Jun 30, 2021 to May 31, 2021v7
  4. Primary completion date: Jan 15, 2021 to Jun 30, 2021v6
  5. Primary completion date: Feb 28, 2020 to Jan 15, 2021
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2024 to Jan 15, 2025
    • Site details revised at 2 of 2 sites
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    v3
  3. Secondary endpoints revised (5)v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will evaluate patients with, at least, one previous procedure of coronary revascularization (surgical, percutaneous or both), that are referred for a new, clinically indicated, diagnostic coronary angiography, to describe their clinical characteristics, management, and prognosis, and will propose a prognosis-oriented classification.
Trial Details
NCT Number NCT03349385
Lead Sponsor Hospital San Carlos, Madrid
Collaborators: Laboratorios Farmacéuticos Rovi, S.A., S&H MEDICAL SCIENCE SERVICE, S.L.
Conditions
(from sponsor)		 Coronary Artery Disease Progression, Coronary Artery Disease of Significant Bypass Graft, Stent Stenosis, Stent Restenosis, Coronary Arteriosclerosis
Related terms Coronary Artery Disease
Enrollment 869 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov